Moderna, Inc. (MRNA)
143.97
+7.35
(+5.38%)
USD |
NASDAQ |
Sep 11, 16:00
144.61
+0.64
(+0.44%)
After-Hours: 20:00
Moderna Price : 143.97 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 137.90 | 149.73 | 135.01 | 143.97 | 15.41M |
| Sep 10, 2026 | 134.86 | 137.13 | 130.38 | 136.62 | 7.874M |
| Sep 09, 2026 | 140.30 | 143.94 | 135.52 | 135.61 | 8.650M |
| Sep 08, 2026 | 145.98 | 147.50 | 139.70 | 140.33 | 10.31M |
| Sep 04, 2026 | 153.62 | 154.69 | 141.52 | 145.55 | 14.97M |
| Sep 03, 2026 | 145.94 | 150.20 | 142.78 | 148.87 | 13.29M |
| Sep 02, 2026 | 151.40 | 156.42 | 146.54 | 150.81 | 16.56M |
| Sep 01, 2026 | 140.25 | 154.70 | 138.09 | 154.27 | 25.83M |
| Aug 31, 2026 | 134.10 | 144.20 | 133.86 | 140.34 | 18.57M |
| Aug 28, 2026 | 137.19 | 138.80 | 133.33 | 137.99 | 25.82M |
| Aug 27, 2026 | 144.18 | 148.59 | 138.54 | 142.77 | 24.99M |
| Aug 26, 2026 | 154.20 | 156.13 | 145.10 | 149.66 | 22.01M |
| Aug 25, 2026 | 143.50 | 161.37 | 141.21 | 158.83 | 49.23M |
| Aug 24, 2026 | 142.70 | 145.50 | 130.00 | 138.89 | 31.59M |
| Aug 21, 2026 | 133.11 | 159.47 | 132.42 | 145.13 | 87.32M |
| Aug 20, 2026 | 150.14 | 155.00 | 128.61 | 133.32 | 99.50M |
| Aug 19, 2026 | 116.02 | 176.66 | 114.46 | 174.38 | 199.25M |
| Aug 18, 2026 | 63.04 | 64.46 | 62.13 | 62.96 | 4.305M |
| Aug 17, 2026 | 64.78 | 65.52 | 62.91 | 64.46 | 3.980M |
| Aug 14, 2026 | 62.89 | 63.78 | 60.82 | 63.32 | 4.701M |
| Aug 13, 2026 | 63.80 | 65.33 | 62.33 | 63.65 | 8.160M |
| Aug 12, 2026 | 60.58 | 64.26 | 59.29 | 63.67 | 6.582M |
| Aug 11, 2026 | 60.21 | 61.40 | 58.60 | 60.57 | 6.556M |
| Aug 10, 2026 | 59.75 | 60.77 | 58.41 | 59.81 | 6.225M |
| Aug 07, 2026 | 54.79 | 59.42 | 54.62 | 59.17 | 6.821M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 20.45 |
| BioNTech SE | 96.73 |
| Twist Bioscience Corp. | 127.22 |
| Intellia Therapeutics, Inc. | 11.74 |
| Replimune Group, Inc. | 12.92 |
Price Related Metrics
| PS Ratio | 25.44 |
| PEG Ratio | -2.906 |
| Price to Book Value | 8.496 |
| Earnings Yield | -5.55% |
| Market Cap | 57.44B |
| PEGY Ratio | -2.906 |